Endpoints News 生物医药· Nicole DeFeudis·· 10 天前AI 评分40
Mirum 计划向 FDA 提交肝炎 D 治疗药物申请
Mirum plans FDA submission for hepatitis D treatment as competition brews
AI 导读
Mirum 的肝炎 D 治疗药物在第二项关键临床试验中取得成功,现正准备向 FDA 提交申请,面临其他竞争产品的挑战。
正文
Mirum’s hepatitis D treatment has succeeded in the second of two pivotal trials. Now comes the next challenge: competing with rivals in a growing market.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news